RESUMO
INTRODUCTION: Keratosis pilaris (KP) is a common, benign skin condition of follicular hyperkeratosis. Although KP is asymptomatic, the cosmetic appearance of KP can lead to psychosocial distress among patients. New emerging treatments are increasingly being utilized. Yet, there is little to no summative data on the treatments of KP and its subtypes. OBJECTIVE: To summarize existing literature on treatments for KP and its subtypes. METHODS: A comprehensive search was performed using Pubmed/MEDLINE, Embase and Web of Science databases. The search identified 1150 non-duplicated articles, and 47 articles were included in the review. The primary outcomes measured were KP treatment type and the degree of improvement following therapy. FINDINGS: Our findings demonstrate that the most supported form of treatment for KP is laser therapy, particularly the QS:Nd YAG laser. Topical treatments - including Mineral Oil-Hydrophil Petrolat, tacrolimus, azelaic acid, and salicylic acid - are also effective at least for improving the appearance of KP. CONCLUSION: While the measured treatment outcomes varied among studies, laser therapy appears to be the most effective form of treatment. Use of topicals also improved KP lesions.
Assuntos
Anormalidades Múltiplas , Doença de Darier , Terapia com Luz de Baixa Intensidade , Anormalidades Múltiplas/terapia , Doença de Darier/terapia , Sobrancelhas/anormalidades , HumanosRESUMO
BACKGROUND: Keratosis pilaris (KP) is a common hereditary keratinization disorder. Keratosis pilaris rubra and KP atrophicans faciei are less frequent variants of the disease. Topical treatments often yield ineffective and temporary results. OBJECTIVE: The objective of this article is to review and assess all the studies that used light and laser devices to treat KP and its variants. MATERIAL AND METHODS: On January 15, 2017, an online search of the MEDLINE, Embase, and Cochrane databases was performed using the following combination of keywords: "keratosis pilaris" and "treatment." RESULTS: Seventeen studies related to light and laser treatments were retained for analysis. The total number of treated patients was 175. Of which, 22 patients had KP atrophicans faciei, 17 patients had KP rubra, and 136 patients had KP. CONCLUSION: Light and laser devices have been emerging as promising therapeutic options for a disfiguring disease that still lacks, until today, an effective long-term treatment.
Assuntos
Anormalidades Múltiplas/terapia , Doença de Darier/terapia , Sobrancelhas/anormalidades , Terapia de Luz Pulsada Intensa/métodos , Terapia com Luz de Baixa Intensidade/métodos , Anormalidades Múltiplas/diagnóstico , Ensaios Clínicos como Assunto , Doença de Darier/diagnóstico , Humanos , Terapia de Luz Pulsada Intensa/instrumentação , Lasers de Corante/uso terapêutico , Lasers de Gás/uso terapêutico , Lasers Semicondutores/uso terapêutico , Lasers de Estado Sólido/uso terapêutico , Terapia com Luz de Baixa Intensidade/instrumentação , Índice de Gravidade de Doença , Resultado do TratamentoRESUMO
OBJECTIVES: Keratosis pilaris (KP) is the condition of the skin with extensive keratin follicular plugging. It may be associated with the erythema. The upper arm extensor area, shoulders, back of neck and thighs, as well as face and the upper trunk are the areas of presentation. Available medications for KP give only symptomatic relief, while some produce serious side effects. There is no proven universal treatment for the disease that can provide complete recovery. Ayurveda management of KP is not yet reported. CASE PRESENTATION: A 26-year-old male patient, presented with main complaints started with papular lesions over his right shoulder, chest and upper back along and later with pustular lesions in the past 2 weeks. The condition was associated with redness, mild swelling and itching. The case was diagnosed as Keratosis pilaris based on its presentation, site, and pathogenesis. Also by analyzing the extent of vitiation of dosas (morbidities), the Vata kapha pitta hara line of treatment was adopted, which was accomplished in two phases i. e. Sodhana Cikitsa and Samana Cikitsa. CONCLUSION: Both internal and external treatments along with diet restrictions were found effective in arresting the pathogenesis and recovery in a short period. All the symptoms associated with the condition were completely cured with no signs of re-occurrence.
Assuntos
Anormalidades Múltiplas/terapia , Doença de Darier/terapia , Sobrancelhas/anormalidades , Ayurveda/métodos , Adulto , Humanos , Masculino , Resultado do TratamentoRESUMO
Keratosis pilaris is a common skin disorder comprising less common variants and rare subtypes, including keratosis pilaris rubra, erythromelanosis follicularis faciei et colli, and the spectrum of keratosis pilaris atrophicans. Data, and critical analysis of existing data, are lacking, so the etiologies, pathogeneses, disease associations, and treatments of these clinical entities are poorly understood. The present article aims to fill this knowledge gap by reviewing literature in the PubMed, EMBASE, and CINAHL databases and providing a comprehensive, analytical summary of the clinical characteristics and pathophysiology of keratosis pilaris and its subtypes through the lens of disease associations, genetics, and pharmacologic etiologies. Histopathologic, genomic, and epidemiologic evidence points to keratosis pilaris as a primary disorder of the pilosebaceous unit as a result of inherited mutations or acquired disruptions in various biomolecular pathways. Recent data highlight aberrant Ras signaling as an important contributor to the pathophysiology of keratosis pilaris and its subtypes. We also evaluate data on treatments for keratosis pilaris and its subtypes, including topical, systemic, and energy-based therapies. The effectiveness of various types of lasers in treating keratosis pilaris and its subtypes deserves wider recognition.
Assuntos
Anormalidades Múltiplas/terapia , Doença de Darier/terapia , Dermabrasão/métodos , Fármacos Dermatológicos/uso terapêutico , Sobrancelhas/anormalidades , Fototerapia/métodos , Anormalidades Múltiplas/diagnóstico , Anormalidades Múltiplas/etiologia , Anormalidades Múltiplas/patologia , Administração Cutânea , Doença de Darier/diagnóstico , Doença de Darier/etiologia , Doença de Darier/patologia , Dermatite Atópica/complicações , Diagnóstico Diferencial , Sobrancelhas/patologia , Proteínas Filagrinas , Humanos , Ictiose/complicações , Ictiose/genética , Proteínas de Filamentos Intermediários/genética , Mutação , Transdução de Sinais/genética , Pele/patologia , Resultado do Tratamento , Proteínas ras/genética , Proteínas ras/metabolismoRESUMO
Ulerythema ophryogenes is a rare cutaneous atrophic disorder that occasionally is associated with Noonan syndrome, de Lange syndrome, Rubinstein-Taybi syndrome, and cardiofaciocutaneous (CFC) syndrome. Often presenting in pediatric patients, the pathogenesis of ulerythema ophryogenes remains unclear, though several genetic causes have been suggested. Treatment recommendations remain anecdotal, but clearance has been noted as the patient ages. Although topical agents have been the mainstay of therapy, recent advancement in laser intervention for treatment of ulerythema ophryogenes is promising.
Assuntos
Anormalidades Múltiplas/fisiopatologia , Doença de Darier/fisiopatologia , Sobrancelhas/anormalidades , Anormalidades Múltiplas/terapia , Anti-Inflamatórios/uso terapêutico , Criança , Doença de Darier/complicações , Doença de Darier/terapia , Síndrome de Cornélia de Lange/complicações , Progressão da Doença , Displasia Ectodérmica/complicações , Sobrancelhas/fisiopatologia , Fácies , Insuficiência de Crescimento/complicações , Cardiopatias Congênitas/complicações , Humanos , Terapia de Luz Pulsada Intensa , Ceratolíticos/uso terapêutico , Lasers de Corante/uso terapêutico , Terapia com Luz de Baixa Intensidade , Síndrome de Noonan/complicações , Síndrome de Rubinstein-Taybi/complicações , Triancinolona/uso terapêuticoRESUMO
BACKGROUND: Current treatment options for keratosis pilaris (KP) are limited and are often found to be unsatisfactory to patients. OBJECTIVE: Pilot study to determine if photopneumatic therapy (PPx) can improve the erythema and skin texture in KP. METHODS: Ten patients with KP were treated with one session of PPx on the upper arm and then evaluated one month later for treatment efficacy. RESULTS: Average investigator-assessed improvement was 27% in erythema and 56% in skin texture roughness. Average patient self-reported improvement was 52% in erythema and 53% in skin texture. The mean satisfaction score was 6.3 on a scale of 1 to 10 (median 7.5) and 8 out of 10 participants reported they would choose to receive PPx for their KP again in the future. LIMITATIONS: Small number of patients, short follow-up period, and lack of blinding of the examiner and the patients making recall bias possible. CONCLUSIONS: One treatment of PPx improved both the erythema and redness associated with KP over at least a one month period.
Assuntos
Anormalidades Múltiplas/terapia , Doença de Darier/terapia , Eritema/terapia , Sobrancelhas/anormalidades , Fototerapia/métodos , Anormalidades Múltiplas/patologia , Adolescente , Adulto , Doença de Darier/patologia , Eritema/etiologia , Sobrancelhas/patologia , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Resultado do Tratamento , Adulto JovemAssuntos
Doença de Darier/terapia , Eletroacupuntura , Adolescente , Adulto , Feminino , Humanos , Adulto JovemRESUMO
BACKGROUND: Darier disease is an autosomal dominant hereditary skin disease that is susceptible to secondary bacterial or fungal infections, but rarely to human papillomavirus (HPV) infections. Multiple or extensive warts from HPV remain a therapeutic challenge, but local hyperthermia is effective. We treated a patient with Darier disease who had superimposed warts in the genital and neck regions. MATERIALS AND METHODS: The patient was treated with tolerable local hyperthermia with infrared light from a halogen lamp (surface temperature, 40°C) to a single target lesion on the genitalia (30 min daily) for 3 consecutive days. RESULTS: Within 2 weeks, the target lesion cleared and synchronous regression of untreated lesions on the neck was observed. CONCLUSIONS: In Darier disease, local hyperthermia treatment of HPV warts in 1 region was effective in treating multiple lesions, including lesions at a remote site, possibly by promoting an immune response against HPV.
Assuntos
Doença de Darier/terapia , Hipertermia Induzida , Verrugas/terapia , Adulto , Humanos , Masculino , Pescoço , EscrotoRESUMO
Erythema annulare centrifugum is an acute dermatosis of unclear etiology, which presents with annular erythematous lesions with marginal scale. Therapeutically, systemic and topical glucocorticosteroids are used primarily. We treated a patient with large lesions in the area of the thighs resistant to a therapy with topical glucocorticosteroids, with topical calcitriol in combination with 311 nm ultraviolet B narrow band phototherapy. After four weeks of treatment the skin lesions had cleared nearly completely without any side effects. The combination topical vitamin D3-analogue calcitriol and 311 nm ultraviolet B narrow band phototherapy was effective and can be regarded as a useful alternative to glucocorticosteroids for erythema annulare centrifugum.